chromic phosphate has been researched along with melphalan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubinstein, L; Walton, LA; Yadusky, A | 1 |
| Boyes, D; Carmichael, J; Fraser, R; Gerulath, A; Kirk, M; Klaassen, D; Levitt, M; Methot, Y; Shelley, W; Starreveld, A | 1 |
| Boyes, D; Gerulath, A; Klaassen, D; Levitt, M; Miller, A; Shelly, W; Starreveld, A | 1 |
| Dent, SF; Klaassen, D; Pater, JL; Whitehead, M; Zee, B | 1 |
1 review(s) available for chromic phosphate and melphalan
| Article | Year |
|---|---|
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
Topics: Adolescent; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Melphalan; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Radiotherapy | 1991 |
4 trial(s) available for chromic phosphate and melphalan
| Article | Year |
|---|---|
Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.
Topics: Adolescent; Adult; Aged; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Melphalan; Middle Aged; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Radiotherapy | 1991 |
Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.
Topics: Chromium; Chromium Compounds; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Melphalan; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Random Allocation | 1988 |
External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: a toxic combination. A National Cancer Institute of Canada Clinical Trials Group Report.
Topics: Brachytherapy; Chromium; Chromium Compounds; Female; Humans; Melphalan; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes | 1985 |
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG).
Topics: Antineoplastic Agents, Alkylating; Brachytherapy; Canada; Chromium Compounds; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Melphalan; Neoplasm Staging; Neoplasms, Second Primary; Ovarian Neoplasms; Phosphates; Survival Rate; Time Factors | 2000 |